GENDER EFFECT ON ANTITHROMBOTIC TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION
Abstract
To study the gender effect on the peculiar features of antithrombotic therapy, 377 patients (213 women and 164 men) with chronic, persistent, or paroxysmal atrial fibrillation aged 27 89 years (mean 67.4±9.53 years) were examined.
About the Authors
N. A. Novikova
ГОУ ВПО Московская медицинская академия имени И.М.Сеченова
Russian Federation
Russian Federation
E. G. Sorokina
ГОУ ВПО Московская медицинская академия имени И.М.Сеченова
Russian Federation
Russian Federation
M. Yu. Gilyarov
ГОУ ВПО Московская медицинская академия имени И.М.Сеченова
Russian Federation
Russian Federation
N. D. Sarkisova
ГОУ ВПО Московская медицинская академия имени И.М.Сеченова
Russian Federation
Russian Federation
References
1. Fuster V., Rydén L.E., Cannom D.S., et al. ACC/AHA/ ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European Society of Cardiology committee for practice guidelines.// Circulation, 2006; 114:257-354
2. Friberg J., Scharling H., Gadsboll N., et al. Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study).// American Journal of Cardiology, 2003; 92(12):1419-1423
3. Olshansky B., Rosenfeld L., Warner A., et al. The AFFIRM Study: Approaches to control rate in atrial fibrillation.// J. Am. Coll. Cardiol., 2004; 43:1201-1208
4. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.// Stroke, 1991; 22:983-988
5. Hart R., Halperin J.L. Atrial fibrillation and stroke. Concepts and controversies// Stroke, 2001; 32:803-808
6. Friberg J., Scharling H., Gadsboll N. et al. Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). American Journal of Cardiology, 2003; 92(12):1419-1423
7. Fang M.C. Singer D.E., Chang Y., Hylek E.M., et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.// Circulation, 2005; 112(12):1687-91
8. Dagres N., Nieuwlaat R., Vardas P., et al. Gender-related differences in presentation, treatment, and outcomes of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on atrial fibrillation.// J. Am. Coll. Cardiol., 2007; 49(5):572-577
9. Hart R.G., Pearce L.A., Aguilar M.I. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.// Ann. Intern. Med., 2007; 146:857-867
10. Carlsson J. Mortality and stroke rates in a trial of Rhythm Control versus Rate Control in atrial fibrillation: results from the STAF Pilot Phase (Strategies of Treatment of Atrial Fibrillation).// J. Amer. Coll. Cardiol., 2001; 38(3):603-604
11. Lip G., Watson T., Shantsila E. Anticoagulation for stroke prevention in atrial fibrillation: is gender important?// European Heart Journal, 2006; 27(16):1893-1894
12. Hylek E., Go A., Chang Y., et al. Effect of intensity of oral anticoagulation on stroke severity and morality in atrial fibrillation// N. Engl. J. Med., 2003; 349:1019-26
Review
For citations:
Novikova N.A., Sorokina E.G., Gilyarov M.Yu., Sarkisova N.D. GENDER EFFECT ON ANTITHROMBOTIC TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION. Journal of Arrhythmology. 2009;(58):21-25. (In Russ.)
Views:
120
Email this article 